Home Articles  
ED Pills - Viagra, Levitra, Cialis
Categories
Archives
Articles
Interesting Facts
Tag

Bremelanotide In Erectile Dysfunction Therapy

Sat,29 October 2011



Palatin Technologies, Inc. announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for erectile dysfunction.  The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old.  The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.

Palatin anticipates completing the study in the current calendar qu



2012 © Copyright. All Rights Reserved